Global Postoperative Pain Control Drug Supply, Demand and Key Producers, 2026-2032
The global Postoperative Pain Control Drug market size is expected to reach $ 7976 million by 2032, rising at a market growth of 6.0% CAGR during the forecast period (2026-2032).
Postoperative Pain Control Drugs encompass a specialized class of acute-use pharmaceuticals formulated to suppress nociceptive (pain-sensing) signaling pathways following surgical trauma. Historically dominated by central nervous system (CNS) mu-opioid receptor agonists like morphine, fentanyl, and hydromorphone, modern postoperative pain protocols have radically shifted toward multimodal analgesia. This clinical strategy combines lower-dose opioids with diverse non-opioid mechanism families to maximize pain control while mitigating systemic side effects like respiratory depression, postoperative nausea and vomiting (PONV), and long-term dependency.
In 2025, global Postoperative Pain Control Drugs production reached approximately 414.08 million doses, with an average global market price of around US$ 12.64 per dose. And global Postoperative Pain Control Drugs production capacity reached approximately 540 million doses. The average gross margin in this industry reached 42.02%.
The supply chain for postoperative pain control drugs requires stringent chemical synthesis compliance, high-barrier sterile filling facilities, and specialized drug delivery carrier matrices. The upstream supply chain provides the foundational Active Pharmaceutical Ingredients (APIs), key chemical precursors, and advanced multi-phase delivery vehicles. Global life sciences chemical suppliers like Lonza Group and Siegfried Holding AG serve as critical upstream contract development and manufacturing organizations (CDMOs), synthesizing high-purity small molecule APIs under strict Current Good Manufacturing Practice (cGMP) regulations. For extended-release formulations, specialized polymer firms provide the upstream lipid matrices and bioresorbable poly(lactic-co-glycolic acid) (PLGA) microspheres required to encapsulate local anesthetics for multi-day local release. Concurrently, primary packaging giants like West Pharmaceutical Services, Inc. supply the critical upstream components, delivering the passivated elastomeric vial stoppers and sterile, ready-to-fill glass cartridges needed to ensure long-term formulation stability.
Conversely, the downstream supply chain spans specialty pharmaceutical innovators, generic drug manufacturers, sterile compounding operators, and institutional healthcare buyers. Major acute care pharmaceutical developers?such as Pacira BioSciences, Inc. (makers of Exparel), Heron Therapeutics, Inc. (Zynrelef), Vertex Pharmaceuticals (Journavx), and global injection specialists like Pfizer Inc. (Pfizer CentreOne)?operate as the primary downstream customers, purchasing raw upstream APIs and custom carrier vehicles to compound, sterilize, and package finished, hospital-ready analgesics. These finished clinical therapeutics are funneled downstream through Tier-1 pharmaceutical distributors including McKesson Corporation, AmerisourceBergen, and Cardinal Health. Ultimately, the vital final downstream enterprise end-users are acute care hospital networks (such as HCA Healthcare) and specialized ambulatory surgical centers (ASCs), which stock these fast-acting therapeutics in automated dispensing cabinets for surgical anesthesiologists and perioperative nursing teams to administer directly to patients entering post-anesthesia care units (PACU).
This report studies the global Postoperative Pain Control Drug production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Postoperative Pain Control Drug and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Postoperative Pain Control Drug that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Postoperative Pain Control Drug total production and demand, 2021-2032, (K Dose)
Global Postoperative Pain Control Drug total production value, 2021-2032, (USD Million)
Global Postoperative Pain Control Drug production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Dose), (based on production site)
Global Postoperative Pain Control Drug consumption by region & country, CAGR, 2021-2032 & (K Dose)
U.S. VS China: Postoperative Pain Control Drug domestic production, consumption, key domestic manufacturers and share
Global Postoperative Pain Control Drug production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Dose)
Global Postoperative Pain Control Drug production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Dose)
Global Postoperative Pain Control Drug production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Dose)
This report profiles key players in the global Postoperative Pain Control Drug market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Mallinckrodt Pharmaceuticals (IE), Pfizer (US), Novartis (CH), Eli Lilly (US), Teva Pharmaceutical Industries (IL), Bayer (DE), Pacira BioSciences (US), Trevena (US), Vertex Pharmaceuticals (US), Heron Therapeutics (US), etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Postoperative Pain Control Drug market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Dose) and average price (US$/Dose) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Postoperative Pain Control Drug Market, By Region:
1. How big is the global Postoperative Pain Control Drug market?
2. What is the demand of the global Postoperative Pain Control Drug market?
3. What is the year over year growth of the global Postoperative Pain Control Drug market?
4. What is the production and production value of the global Postoperative Pain Control Drug market?
5. Who are the key producers in the global Postoperative Pain Control Drug market?
6. What are the growth factors driving the market demand?
Postoperative Pain Control Drugs encompass a specialized class of acute-use pharmaceuticals formulated to suppress nociceptive (pain-sensing) signaling pathways following surgical trauma. Historically dominated by central nervous system (CNS) mu-opioid receptor agonists like morphine, fentanyl, and hydromorphone, modern postoperative pain protocols have radically shifted toward multimodal analgesia. This clinical strategy combines lower-dose opioids with diverse non-opioid mechanism families to maximize pain control while mitigating systemic side effects like respiratory depression, postoperative nausea and vomiting (PONV), and long-term dependency.
In 2025, global Postoperative Pain Control Drugs production reached approximately 414.08 million doses, with an average global market price of around US$ 12.64 per dose. And global Postoperative Pain Control Drugs production capacity reached approximately 540 million doses. The average gross margin in this industry reached 42.02%.
The supply chain for postoperative pain control drugs requires stringent chemical synthesis compliance, high-barrier sterile filling facilities, and specialized drug delivery carrier matrices. The upstream supply chain provides the foundational Active Pharmaceutical Ingredients (APIs), key chemical precursors, and advanced multi-phase delivery vehicles. Global life sciences chemical suppliers like Lonza Group and Siegfried Holding AG serve as critical upstream contract development and manufacturing organizations (CDMOs), synthesizing high-purity small molecule APIs under strict Current Good Manufacturing Practice (cGMP) regulations. For extended-release formulations, specialized polymer firms provide the upstream lipid matrices and bioresorbable poly(lactic-co-glycolic acid) (PLGA) microspheres required to encapsulate local anesthetics for multi-day local release. Concurrently, primary packaging giants like West Pharmaceutical Services, Inc. supply the critical upstream components, delivering the passivated elastomeric vial stoppers and sterile, ready-to-fill glass cartridges needed to ensure long-term formulation stability.
Conversely, the downstream supply chain spans specialty pharmaceutical innovators, generic drug manufacturers, sterile compounding operators, and institutional healthcare buyers. Major acute care pharmaceutical developers?such as Pacira BioSciences, Inc. (makers of Exparel), Heron Therapeutics, Inc. (Zynrelef), Vertex Pharmaceuticals (Journavx), and global injection specialists like Pfizer Inc. (Pfizer CentreOne)?operate as the primary downstream customers, purchasing raw upstream APIs and custom carrier vehicles to compound, sterilize, and package finished, hospital-ready analgesics. These finished clinical therapeutics are funneled downstream through Tier-1 pharmaceutical distributors including McKesson Corporation, AmerisourceBergen, and Cardinal Health. Ultimately, the vital final downstream enterprise end-users are acute care hospital networks (such as HCA Healthcare) and specialized ambulatory surgical centers (ASCs), which stock these fast-acting therapeutics in automated dispensing cabinets for surgical anesthesiologists and perioperative nursing teams to administer directly to patients entering post-anesthesia care units (PACU).
This report studies the global Postoperative Pain Control Drug production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Postoperative Pain Control Drug and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Postoperative Pain Control Drug that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Postoperative Pain Control Drug total production and demand, 2021-2032, (K Dose)
Global Postoperative Pain Control Drug total production value, 2021-2032, (USD Million)
Global Postoperative Pain Control Drug production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Dose), (based on production site)
Global Postoperative Pain Control Drug consumption by region & country, CAGR, 2021-2032 & (K Dose)
U.S. VS China: Postoperative Pain Control Drug domestic production, consumption, key domestic manufacturers and share
Global Postoperative Pain Control Drug production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Dose)
Global Postoperative Pain Control Drug production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Dose)
Global Postoperative Pain Control Drug production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Dose)
This report profiles key players in the global Postoperative Pain Control Drug market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Mallinckrodt Pharmaceuticals (IE), Pfizer (US), Novartis (CH), Eli Lilly (US), Teva Pharmaceutical Industries (IL), Bayer (DE), Pacira BioSciences (US), Trevena (US), Vertex Pharmaceuticals (US), Heron Therapeutics (US), etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Postoperative Pain Control Drug market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Dose) and average price (US$/Dose) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Postoperative Pain Control Drug Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Opioids
- NSAIDs
- Local Anesthetics
- Tricyclic Antidepressants
- Antiepileptic Drugs
- Others
- Intravenous
- Oral
- Others
- Systemic
- Regional
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Others
- Mallinckrodt Pharmaceuticals (IE)
- Pfizer (US)
- Novartis (CH)
- Eli Lilly (US)
- Teva Pharmaceutical Industries (IL)
- Bayer (DE)
- Pacira BioSciences (US)
- Trevena (US)
- Vertex Pharmaceuticals (US)
- Heron Therapeutics (US)
- Nanjing Delova Biotech (CN)
- Jiangsu Nhwa Pharmaceutical (CN)
1. How big is the global Postoperative Pain Control Drug market?
2. What is the demand of the global Postoperative Pain Control Drug market?
3. What is the year over year growth of the global Postoperative Pain Control Drug market?
4. What is the production and production value of the global Postoperative Pain Control Drug market?
5. Who are the key producers in the global Postoperative Pain Control Drug market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Postoperative Pain Control Drug Introduction
1.2 World Postoperative Pain Control Drug Supply & Forecast
1.2.1 World Postoperative Pain Control Drug Production Value (2021 & 2025 & 2032)
1.2.2 World Postoperative Pain Control Drug Production (2021-2032)
1.2.3 World Postoperative Pain Control Drug Pricing Trends (2021-2032)
1.3 World Postoperative Pain Control Drug Production by Region (Based on Production Site)
1.3.1 World Postoperative Pain Control Drug Production Value by Region (2021-2032)
1.3.2 World Postoperative Pain Control Drug Production by Region (2021-2032)
1.3.3 World Postoperative Pain Control Drug Average Price by Region (2021-2032)
1.3.4 North America Postoperative Pain Control Drug Production (2021-2032)
1.3.5 Europe Postoperative Pain Control Drug Production (2021-2032)
1.3.6 China Postoperative Pain Control Drug Production (2021-2032)
1.3.7 Japan Postoperative Pain Control Drug Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Postoperative Pain Control Drug Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Postoperative Pain Control Drug Major Market Trends
2 DEMAND SUMMARY
2.1 World Postoperative Pain Control Drug Demand (2021-2032)
2.2 World Postoperative Pain Control Drug Consumption by Region
2.2.1 World Postoperative Pain Control Drug Consumption by Region (2021-2026)
2.2.2 World Postoperative Pain Control Drug Consumption Forecast by Region (2027-2032)
2.3 United States Postoperative Pain Control Drug Consumption (2021-2032)
2.4 China Postoperative Pain Control Drug Consumption (2021-2032)
2.5 Europe Postoperative Pain Control Drug Consumption (2021-2032)
2.6 Japan Postoperative Pain Control Drug Consumption (2021-2032)
2.7 South Korea Postoperative Pain Control Drug Consumption (2021-2032)
2.8 ASEAN Postoperative Pain Control Drug Consumption (2021-2032)
2.9 India Postoperative Pain Control Drug Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Postoperative Pain Control Drug Production Value by Manufacturer (2021-2026)
3.2 World Postoperative Pain Control Drug Production by Manufacturer (2021-2026)
3.3 World Postoperative Pain Control Drug Average Price by Manufacturer (2021-2026)
3.4 Postoperative Pain Control Drug Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Postoperative Pain Control Drug Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Postoperative Pain Control Drug in 2025
3.5.3 Global Concentration Ratios (CR8) for Postoperative Pain Control Drug in 2025
3.6 Postoperative Pain Control Drug Market: Overall Company Footprint Analysis
3.6.1 Postoperative Pain Control Drug Market: Region Footprint
3.6.2 Postoperative Pain Control Drug Market: Company Product Type Footprint
3.6.3 Postoperative Pain Control Drug Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Postoperative Pain Control Drug Production Value Comparison
4.1.1 United States VS China: Postoperative Pain Control Drug Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Postoperative Pain Control Drug Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Postoperative Pain Control Drug Production Comparison
4.2.1 United States VS China: Postoperative Pain Control Drug Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Postoperative Pain Control Drug Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Postoperative Pain Control Drug Consumption Comparison
4.3.1 United States VS China: Postoperative Pain Control Drug Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Postoperative Pain Control Drug Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Postoperative Pain Control Drug Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Postoperative Pain Control Drug Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Postoperative Pain Control Drug Production Value (2021-2026)
4.4.3 United States Based Manufacturers Postoperative Pain Control Drug Production (2021-2026)
4.5 China Based Postoperative Pain Control Drug Manufacturers and Market Share
4.5.1 China Based Postoperative Pain Control Drug Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Postoperative Pain Control Drug Production Value (2021-2026)
4.5.3 China Based Manufacturers Postoperative Pain Control Drug Production (2021-2026)
4.6 Rest of World Based Postoperative Pain Control Drug Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Postoperative Pain Control Drug Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Postoperative Pain Control Drug Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Postoperative Pain Control Drug Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Postoperative Pain Control Drug Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Opioids
5.2.2 NSAIDs
5.2.3 Local Anesthetics
5.2.4 Tricyclic Antidepressants
5.2.5 Antiepileptic Drugs
5.2.6 Others
5.3 Market Segment by Type
5.3.1 World Postoperative Pain Control Drug Production by Type (2021-2032)
5.3.2 World Postoperative Pain Control Drug Production Value by Type (2021-2032)
5.3.3 World Postoperative Pain Control Drug Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY DOSAGE
6.1 World Postoperative Pain Control Drug Market Size Overview by Dosage: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Dosage
6.2.1 Intravenous
6.2.2 Oral
6.2.3 Others
6.3 Market Segment by Dosage
6.3.1 World Postoperative Pain Control Drug Production by Dosage (2021-2032)
6.3.2 World Postoperative Pain Control Drug Production Value by Dosage (2021-2032)
6.3.3 World Postoperative Pain Control Drug Average Price by Dosage (2021-2032)
7 MARKET ANALYSIS BY ACTION AREA
7.1 World Postoperative Pain Control Drug Market Size Overview by Action Area: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Action Area
7.2.1 Systemic
7.2.2 Regional
7.3 Market Segment by Action Area
7.3.1 World Postoperative Pain Control Drug Production by Action Area (2021-2032)
7.3.2 World Postoperative Pain Control Drug Production Value by Action Area (2021-2032)
7.3.3 World Postoperative Pain Control Drug Average Price by Action Area (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Postoperative Pain Control Drug Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Hospital Pharmacies
8.2.2 Retail Pharmacies
8.2.3 Online Pharmacies
8.2.4 Others
8.3 Market Segment by Application
8.3.1 World Postoperative Pain Control Drug Production by Application (2021-2032)
8.3.2 World Postoperative Pain Control Drug Production Value by Application (2021-2032)
8.3.3 World Postoperative Pain Control Drug Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 Mallinckrodt Pharmaceuticals (IE)
9.1.1 Mallinckrodt Pharmaceuticals (IE) Details
9.1.2 Mallinckrodt Pharmaceuticals (IE) Major Business
9.1.3 Mallinckrodt Pharmaceuticals (IE) Postoperative Pain Control Drug Product and Services
9.1.4 Mallinckrodt Pharmaceuticals (IE) Postoperative Pain Control Drug Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 Mallinckrodt Pharmaceuticals (IE) Recent Developments/Updates
9.1.6 Mallinckrodt Pharmaceuticals (IE) Competitive Strengths & Weaknesses
9.2 Pfizer (US)
9.2.1 Pfizer (US) Details
9.2.2 Pfizer (US) Major Business
9.2.3 Pfizer (US) Postoperative Pain Control Drug Product and Services
9.2.4 Pfizer (US) Postoperative Pain Control Drug Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 Pfizer (US) Recent Developments/Updates
9.2.6 Pfizer (US) Competitive Strengths & Weaknesses
9.3 Novartis (CH)
9.3.1 Novartis (CH) Details
9.3.2 Novartis (CH) Major Business
9.3.3 Novartis (CH) Postoperative Pain Control Drug Product and Services
9.3.4 Novartis (CH) Postoperative Pain Control Drug Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 Novartis (CH) Recent Developments/Updates
9.3.6 Novartis (CH) Competitive Strengths & Weaknesses
9.4 Eli Lilly (US)
9.4.1 Eli Lilly (US) Details
9.4.2 Eli Lilly (US) Major Business
9.4.3 Eli Lilly (US) Postoperative Pain Control Drug Product and Services
9.4.4 Eli Lilly (US) Postoperative Pain Control Drug Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 Eli Lilly (US) Recent Developments/Updates
9.4.6 Eli Lilly (US) Competitive Strengths & Weaknesses
9.5 Teva Pharmaceutical Industries (IL)
9.5.1 Teva Pharmaceutical Industries (IL) Details
9.5.2 Teva Pharmaceutical Industries (IL) Major Business
9.5.3 Teva Pharmaceutical Industries (IL) Postoperative Pain Control Drug Product and Services
9.5.4 Teva Pharmaceutical Industries (IL) Postoperative Pain Control Drug Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 Teva Pharmaceutical Industries (IL) Recent Developments/Updates
9.5.6 Teva Pharmaceutical Industries (IL) Competitive Strengths & Weaknesses
9.6 Bayer (DE)
9.6.1 Bayer (DE) Details
9.6.2 Bayer (DE) Major Business
9.6.3 Bayer (DE) Postoperative Pain Control Drug Product and Services
9.6.4 Bayer (DE) Postoperative Pain Control Drug Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 Bayer (DE) Recent Developments/Updates
9.6.6 Bayer (DE) Competitive Strengths & Weaknesses
9.7 Pacira BioSciences (US)
9.7.1 Pacira BioSciences (US) Details
9.7.2 Pacira BioSciences (US) Major Business
9.7.3 Pacira BioSciences (US) Postoperative Pain Control Drug Product and Services
9.7.4 Pacira BioSciences (US) Postoperative Pain Control Drug Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.7.5 Pacira BioSciences (US) Recent Developments/Updates
9.7.6 Pacira BioSciences (US) Competitive Strengths & Weaknesses
9.8 Trevena (US)
9.8.1 Trevena (US) Details
9.8.2 Trevena (US) Major Business
9.8.3 Trevena (US) Postoperative Pain Control Drug Product and Services
9.8.4 Trevena (US) Postoperative Pain Control Drug Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.8.5 Trevena (US) Recent Developments/Updates
9.8.6 Trevena (US) Competitive Strengths & Weaknesses
9.9 Vertex Pharmaceuticals (US)
9.9.1 Vertex Pharmaceuticals (US) Details
9.9.2 Vertex Pharmaceuticals (US) Major Business
9.9.3 Vertex Pharmaceuticals (US) Postoperative Pain Control Drug Product and Services
9.9.4 Vertex Pharmaceuticals (US) Postoperative Pain Control Drug Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.9.5 Vertex Pharmaceuticals (US) Recent Developments/Updates
9.9.6 Vertex Pharmaceuticals (US) Competitive Strengths & Weaknesses
9.10 Heron Therapeutics (US)
9.10.1 Heron Therapeutics (US) Details
9.10.2 Heron Therapeutics (US) Major Business
9.10.3 Heron Therapeutics (US) Postoperative Pain Control Drug Product and Services
9.10.4 Heron Therapeutics (US) Postoperative Pain Control Drug Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.10.5 Heron Therapeutics (US) Recent Developments/Updates
9.10.6 Heron Therapeutics (US) Competitive Strengths & Weaknesses
9.11 Nanjing Delova Biotech (CN)
9.11.1 Nanjing Delova Biotech (CN) Details
9.11.2 Nanjing Delova Biotech (CN) Major Business
9.11.3 Nanjing Delova Biotech (CN) Postoperative Pain Control Drug Product and Services
9.11.4 Nanjing Delova Biotech (CN) Postoperative Pain Control Drug Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.11.5 Nanjing Delova Biotech (CN) Recent Developments/Updates
9.11.6 Nanjing Delova Biotech (CN) Competitive Strengths & Weaknesses
9.12 Jiangsu Nhwa Pharmaceutical (CN)
9.12.1 Jiangsu Nhwa Pharmaceutical (CN) Details
9.12.2 Jiangsu Nhwa Pharmaceutical (CN) Major Business
9.12.3 Jiangsu Nhwa Pharmaceutical (CN) Postoperative Pain Control Drug Product and Services
9.12.4 Jiangsu Nhwa Pharmaceutical (CN) Postoperative Pain Control Drug Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.12.5 Jiangsu Nhwa Pharmaceutical (CN) Recent Developments/Updates
9.12.6 Jiangsu Nhwa Pharmaceutical (CN) Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Postoperative Pain Control Drug Industry Chain
10.2 Postoperative Pain Control Drug Upstream Analysis
10.2.1 Postoperative Pain Control Drug Core Raw Materials
10.2.2 Main Manufacturers of Postoperative Pain Control Drug Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Postoperative Pain Control Drug Production Mode
10.6 Postoperative Pain Control Drug Procurement Model
10.7 Postoperative Pain Control Drug Industry Sales Model and Sales Channels
10.7.1 Postoperative Pain Control Drug Sales Model
10.7.2 Postoperative Pain Control Drug Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Postoperative Pain Control Drug Introduction
1.2 World Postoperative Pain Control Drug Supply & Forecast
1.2.1 World Postoperative Pain Control Drug Production Value (2021 & 2025 & 2032)
1.2.2 World Postoperative Pain Control Drug Production (2021-2032)
1.2.3 World Postoperative Pain Control Drug Pricing Trends (2021-2032)
1.3 World Postoperative Pain Control Drug Production by Region (Based on Production Site)
1.3.1 World Postoperative Pain Control Drug Production Value by Region (2021-2032)
1.3.2 World Postoperative Pain Control Drug Production by Region (2021-2032)
1.3.3 World Postoperative Pain Control Drug Average Price by Region (2021-2032)
1.3.4 North America Postoperative Pain Control Drug Production (2021-2032)
1.3.5 Europe Postoperative Pain Control Drug Production (2021-2032)
1.3.6 China Postoperative Pain Control Drug Production (2021-2032)
1.3.7 Japan Postoperative Pain Control Drug Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Postoperative Pain Control Drug Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Postoperative Pain Control Drug Major Market Trends
2 DEMAND SUMMARY
2.1 World Postoperative Pain Control Drug Demand (2021-2032)
2.2 World Postoperative Pain Control Drug Consumption by Region
2.2.1 World Postoperative Pain Control Drug Consumption by Region (2021-2026)
2.2.2 World Postoperative Pain Control Drug Consumption Forecast by Region (2027-2032)
2.3 United States Postoperative Pain Control Drug Consumption (2021-2032)
2.4 China Postoperative Pain Control Drug Consumption (2021-2032)
2.5 Europe Postoperative Pain Control Drug Consumption (2021-2032)
2.6 Japan Postoperative Pain Control Drug Consumption (2021-2032)
2.7 South Korea Postoperative Pain Control Drug Consumption (2021-2032)
2.8 ASEAN Postoperative Pain Control Drug Consumption (2021-2032)
2.9 India Postoperative Pain Control Drug Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Postoperative Pain Control Drug Production Value by Manufacturer (2021-2026)
3.2 World Postoperative Pain Control Drug Production by Manufacturer (2021-2026)
3.3 World Postoperative Pain Control Drug Average Price by Manufacturer (2021-2026)
3.4 Postoperative Pain Control Drug Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Postoperative Pain Control Drug Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Postoperative Pain Control Drug in 2025
3.5.3 Global Concentration Ratios (CR8) for Postoperative Pain Control Drug in 2025
3.6 Postoperative Pain Control Drug Market: Overall Company Footprint Analysis
3.6.1 Postoperative Pain Control Drug Market: Region Footprint
3.6.2 Postoperative Pain Control Drug Market: Company Product Type Footprint
3.6.3 Postoperative Pain Control Drug Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Postoperative Pain Control Drug Production Value Comparison
4.1.1 United States VS China: Postoperative Pain Control Drug Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Postoperative Pain Control Drug Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Postoperative Pain Control Drug Production Comparison
4.2.1 United States VS China: Postoperative Pain Control Drug Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Postoperative Pain Control Drug Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Postoperative Pain Control Drug Consumption Comparison
4.3.1 United States VS China: Postoperative Pain Control Drug Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Postoperative Pain Control Drug Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Postoperative Pain Control Drug Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Postoperative Pain Control Drug Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Postoperative Pain Control Drug Production Value (2021-2026)
4.4.3 United States Based Manufacturers Postoperative Pain Control Drug Production (2021-2026)
4.5 China Based Postoperative Pain Control Drug Manufacturers and Market Share
4.5.1 China Based Postoperative Pain Control Drug Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Postoperative Pain Control Drug Production Value (2021-2026)
4.5.3 China Based Manufacturers Postoperative Pain Control Drug Production (2021-2026)
4.6 Rest of World Based Postoperative Pain Control Drug Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Postoperative Pain Control Drug Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Postoperative Pain Control Drug Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Postoperative Pain Control Drug Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Postoperative Pain Control Drug Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Opioids
5.2.2 NSAIDs
5.2.3 Local Anesthetics
5.2.4 Tricyclic Antidepressants
5.2.5 Antiepileptic Drugs
5.2.6 Others
5.3 Market Segment by Type
5.3.1 World Postoperative Pain Control Drug Production by Type (2021-2032)
5.3.2 World Postoperative Pain Control Drug Production Value by Type (2021-2032)
5.3.3 World Postoperative Pain Control Drug Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY DOSAGE
6.1 World Postoperative Pain Control Drug Market Size Overview by Dosage: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Dosage
6.2.1 Intravenous
6.2.2 Oral
6.2.3 Others
6.3 Market Segment by Dosage
6.3.1 World Postoperative Pain Control Drug Production by Dosage (2021-2032)
6.3.2 World Postoperative Pain Control Drug Production Value by Dosage (2021-2032)
6.3.3 World Postoperative Pain Control Drug Average Price by Dosage (2021-2032)
7 MARKET ANALYSIS BY ACTION AREA
7.1 World Postoperative Pain Control Drug Market Size Overview by Action Area: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Action Area
7.2.1 Systemic
7.2.2 Regional
7.3 Market Segment by Action Area
7.3.1 World Postoperative Pain Control Drug Production by Action Area (2021-2032)
7.3.2 World Postoperative Pain Control Drug Production Value by Action Area (2021-2032)
7.3.3 World Postoperative Pain Control Drug Average Price by Action Area (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Postoperative Pain Control Drug Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Hospital Pharmacies
8.2.2 Retail Pharmacies
8.2.3 Online Pharmacies
8.2.4 Others
8.3 Market Segment by Application
8.3.1 World Postoperative Pain Control Drug Production by Application (2021-2032)
8.3.2 World Postoperative Pain Control Drug Production Value by Application (2021-2032)
8.3.3 World Postoperative Pain Control Drug Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 Mallinckrodt Pharmaceuticals (IE)
9.1.1 Mallinckrodt Pharmaceuticals (IE) Details
9.1.2 Mallinckrodt Pharmaceuticals (IE) Major Business
9.1.3 Mallinckrodt Pharmaceuticals (IE) Postoperative Pain Control Drug Product and Services
9.1.4 Mallinckrodt Pharmaceuticals (IE) Postoperative Pain Control Drug Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 Mallinckrodt Pharmaceuticals (IE) Recent Developments/Updates
9.1.6 Mallinckrodt Pharmaceuticals (IE) Competitive Strengths & Weaknesses
9.2 Pfizer (US)
9.2.1 Pfizer (US) Details
9.2.2 Pfizer (US) Major Business
9.2.3 Pfizer (US) Postoperative Pain Control Drug Product and Services
9.2.4 Pfizer (US) Postoperative Pain Control Drug Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 Pfizer (US) Recent Developments/Updates
9.2.6 Pfizer (US) Competitive Strengths & Weaknesses
9.3 Novartis (CH)
9.3.1 Novartis (CH) Details
9.3.2 Novartis (CH) Major Business
9.3.3 Novartis (CH) Postoperative Pain Control Drug Product and Services
9.3.4 Novartis (CH) Postoperative Pain Control Drug Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 Novartis (CH) Recent Developments/Updates
9.3.6 Novartis (CH) Competitive Strengths & Weaknesses
9.4 Eli Lilly (US)
9.4.1 Eli Lilly (US) Details
9.4.2 Eli Lilly (US) Major Business
9.4.3 Eli Lilly (US) Postoperative Pain Control Drug Product and Services
9.4.4 Eli Lilly (US) Postoperative Pain Control Drug Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 Eli Lilly (US) Recent Developments/Updates
9.4.6 Eli Lilly (US) Competitive Strengths & Weaknesses
9.5 Teva Pharmaceutical Industries (IL)
9.5.1 Teva Pharmaceutical Industries (IL) Details
9.5.2 Teva Pharmaceutical Industries (IL) Major Business
9.5.3 Teva Pharmaceutical Industries (IL) Postoperative Pain Control Drug Product and Services
9.5.4 Teva Pharmaceutical Industries (IL) Postoperative Pain Control Drug Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 Teva Pharmaceutical Industries (IL) Recent Developments/Updates
9.5.6 Teva Pharmaceutical Industries (IL) Competitive Strengths & Weaknesses
9.6 Bayer (DE)
9.6.1 Bayer (DE) Details
9.6.2 Bayer (DE) Major Business
9.6.3 Bayer (DE) Postoperative Pain Control Drug Product and Services
9.6.4 Bayer (DE) Postoperative Pain Control Drug Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 Bayer (DE) Recent Developments/Updates
9.6.6 Bayer (DE) Competitive Strengths & Weaknesses
9.7 Pacira BioSciences (US)
9.7.1 Pacira BioSciences (US) Details
9.7.2 Pacira BioSciences (US) Major Business
9.7.3 Pacira BioSciences (US) Postoperative Pain Control Drug Product and Services
9.7.4 Pacira BioSciences (US) Postoperative Pain Control Drug Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.7.5 Pacira BioSciences (US) Recent Developments/Updates
9.7.6 Pacira BioSciences (US) Competitive Strengths & Weaknesses
9.8 Trevena (US)
9.8.1 Trevena (US) Details
9.8.2 Trevena (US) Major Business
9.8.3 Trevena (US) Postoperative Pain Control Drug Product and Services
9.8.4 Trevena (US) Postoperative Pain Control Drug Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.8.5 Trevena (US) Recent Developments/Updates
9.8.6 Trevena (US) Competitive Strengths & Weaknesses
9.9 Vertex Pharmaceuticals (US)
9.9.1 Vertex Pharmaceuticals (US) Details
9.9.2 Vertex Pharmaceuticals (US) Major Business
9.9.3 Vertex Pharmaceuticals (US) Postoperative Pain Control Drug Product and Services
9.9.4 Vertex Pharmaceuticals (US) Postoperative Pain Control Drug Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.9.5 Vertex Pharmaceuticals (US) Recent Developments/Updates
9.9.6 Vertex Pharmaceuticals (US) Competitive Strengths & Weaknesses
9.10 Heron Therapeutics (US)
9.10.1 Heron Therapeutics (US) Details
9.10.2 Heron Therapeutics (US) Major Business
9.10.3 Heron Therapeutics (US) Postoperative Pain Control Drug Product and Services
9.10.4 Heron Therapeutics (US) Postoperative Pain Control Drug Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.10.5 Heron Therapeutics (US) Recent Developments/Updates
9.10.6 Heron Therapeutics (US) Competitive Strengths & Weaknesses
9.11 Nanjing Delova Biotech (CN)
9.11.1 Nanjing Delova Biotech (CN) Details
9.11.2 Nanjing Delova Biotech (CN) Major Business
9.11.3 Nanjing Delova Biotech (CN) Postoperative Pain Control Drug Product and Services
9.11.4 Nanjing Delova Biotech (CN) Postoperative Pain Control Drug Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.11.5 Nanjing Delova Biotech (CN) Recent Developments/Updates
9.11.6 Nanjing Delova Biotech (CN) Competitive Strengths & Weaknesses
9.12 Jiangsu Nhwa Pharmaceutical (CN)
9.12.1 Jiangsu Nhwa Pharmaceutical (CN) Details
9.12.2 Jiangsu Nhwa Pharmaceutical (CN) Major Business
9.12.3 Jiangsu Nhwa Pharmaceutical (CN) Postoperative Pain Control Drug Product and Services
9.12.4 Jiangsu Nhwa Pharmaceutical (CN) Postoperative Pain Control Drug Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.12.5 Jiangsu Nhwa Pharmaceutical (CN) Recent Developments/Updates
9.12.6 Jiangsu Nhwa Pharmaceutical (CN) Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Postoperative Pain Control Drug Industry Chain
10.2 Postoperative Pain Control Drug Upstream Analysis
10.2.1 Postoperative Pain Control Drug Core Raw Materials
10.2.2 Main Manufacturers of Postoperative Pain Control Drug Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Postoperative Pain Control Drug Production Mode
10.6 Postoperative Pain Control Drug Procurement Model
10.7 Postoperative Pain Control Drug Industry Sales Model and Sales Channels
10.7.1 Postoperative Pain Control Drug Sales Model
10.7.2 Postoperative Pain Control Drug Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Postoperative Pain Control Drug Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Postoperative Pain Control Drug Production Value by Region (2021-2026) & (USD Million)
Table 3. World Postoperative Pain Control Drug Production Value by Region (2027-2032) & (USD Million)
Table 4. World Postoperative Pain Control Drug Production Value Market Share by Region (2021-2026)
Table 5. World Postoperative Pain Control Drug Production Value Market Share by Region (2027-2032)
Table 6. World Postoperative Pain Control Drug Production by Region (2021-2026) & (K Dose)
Table 7. World Postoperative Pain Control Drug Production by Region (2027-2032) & (K Dose)
Table 8. World Postoperative Pain Control Drug Production Market Share by Region (2021-2026)
Table 9. World Postoperative Pain Control Drug Production Market Share by Region (2027-2032)
Table 10. World Postoperative Pain Control Drug Average Price by Region (2021-2026) & (US$/Dose)
Table 11. World Postoperative Pain Control Drug Average Price by Region (2027-2032) & (US$/Dose)
Table 12. Postoperative Pain Control Drug Major Market Trends
Table 13. World Postoperative Pain Control Drug Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Dose)
Table 14. World Postoperative Pain Control Drug Consumption by Region (2021-2026) & (K Dose)
Table 15. World Postoperative Pain Control Drug Consumption Forecast by Region (2027-2032) & (K Dose)
Table 16. World Postoperative Pain Control Drug Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Postoperative Pain Control Drug Producers in 2025
Table 18. World Postoperative Pain Control Drug Production by Manufacturer (2021-2026) & (K Dose)
Table 19. Production Market Share of Key Postoperative Pain Control Drug Producers in 2025
Table 20. World Postoperative Pain Control Drug Average Price by Manufacturer (2021-2026) & (US$/Dose)
Table 21. Global Postoperative Pain Control Drug Company Evaluation Quadrant
Table 22. World Postoperative Pain Control Drug Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Postoperative Pain Control Drug Production Site of Key Manufacturer
Table 24. Postoperative Pain Control Drug Market: Company Product Type Footprint
Table 25. Postoperative Pain Control Drug Market: Company Product Application Footprint
Table 26. Postoperative Pain Control Drug Competitive Factors
Table 27. Postoperative Pain Control Drug New Entrant and Capacity Expansion Plans
Table 28. Postoperative Pain Control Drug Mergers & Acquisitions Activity
Table 29. United States VS China Postoperative Pain Control Drug Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Postoperative Pain Control Drug Production Comparison, (2021 & 2025 & 2032) & (K Dose)
Table 31. United States VS China Postoperative Pain Control Drug Consumption Comparison, (2021 & 2025 & 2032) & (K Dose)
Table 32. United States Based Postoperative Pain Control Drug Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Postoperative Pain Control Drug Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Postoperative Pain Control Drug Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Postoperative Pain Control Drug Production (2021-2026) & (K Dose)
Table 36. United States Based Manufacturers Postoperative Pain Control Drug Production Market Share (2021-2026)
Table 37. China Based Postoperative Pain Control Drug Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Postoperative Pain Control Drug Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Postoperative Pain Control Drug Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Postoperative Pain Control Drug Production, (2021-2026) & (K Dose)
Table 41. China Based Manufacturers Postoperative Pain Control Drug Production Market Share (2021-2026)
Table 42. Rest of World Based Postoperative Pain Control Drug Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Postoperative Pain Control Drug Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Postoperative Pain Control Drug Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Postoperative Pain Control Drug Production, (2021-2026) & (K Dose)
Table 46. Rest of World Based Manufacturers Postoperative Pain Control Drug Production Market Share (2021-2026)
Table 47. World Postoperative Pain Control Drug Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Postoperative Pain Control Drug Production by Type (2021-2026) & (K Dose)
Table 49. World Postoperative Pain Control Drug Production by Type (2027-2032) & (K Dose)
Table 50. World Postoperative Pain Control Drug Production Value by Type (2021-2026) & (USD Million)
Table 51. World Postoperative Pain Control Drug Production Value by Type (2027-2032) & (USD Million)
Table 52. World Postoperative Pain Control Drug Average Price by Type (2021-2026) & (US$/Dose)
Table 53. World Postoperative Pain Control Drug Average Price by Type (2027-2032) & (US$/Dose)
Table 54. World Postoperative Pain Control Drug Production Value by Dosage, (USD Million), 2021 & 2025 & 2032
Table 55. World Postoperative Pain Control Drug Production by Dosage (2021-2026) & (K Dose)
Table 56. World Postoperative Pain Control Drug Production by Dosage (2027-2032) & (K Dose)
Table 57. World Postoperative Pain Control Drug Production Value by Dosage (2021-2026) & (USD Million)
Table 58. World Postoperative Pain Control Drug Production Value by Dosage (2027-2032) & (USD Million)
Table 59. World Postoperative Pain Control Drug Average Price by Dosage (2021-2026) & (US$/Dose)
Table 60. World Postoperative Pain Control Drug Average Price by Dosage (2027-2032) & (US$/Dose)
Table 61. World Postoperative Pain Control Drug Production Value by Action Area, (USD Million), 2021 & 2025 & 2032
Table 62. World Postoperative Pain Control Drug Production by Action Area (2021-2026) & (K Dose)
Table 63. World Postoperative Pain Control Drug Production by Action Area (2027-2032) & (K Dose)
Table 64. World Postoperative Pain Control Drug Production Value by Action Area (2021-2026) & (USD Million)
Table 65. World Postoperative Pain Control Drug Production Value by Action Area (2027-2032) & (USD Million)
Table 66. World Postoperative Pain Control Drug Average Price by Action Area (2021-2026) & (US$/Dose)
Table 67. World Postoperative Pain Control Drug Average Price by Action Area (2027-2032) & (US$/Dose)
Table 68. World Postoperative Pain Control Drug Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Postoperative Pain Control Drug Production by Application (2021-2026) & (K Dose)
Table 70. World Postoperative Pain Control Drug Production by Application (2027-2032) & (K Dose)
Table 71. World Postoperative Pain Control Drug Production Value by Application (2021-2026) & (USD Million)
Table 72. World Postoperative Pain Control Drug Production Value by Application (2027-2032) & (USD Million)
Table 73. World Postoperative Pain Control Drug Average Price by Application (2021-2026) & (US$/Dose)
Table 74. World Postoperative Pain Control Drug Average Price by Application (2027-2032) & (US$/Dose)
Table 75. Mallinckrodt Pharmaceuticals (IE) Basic Information, Manufacturing Base and Competitors
Table 76. Mallinckrodt Pharmaceuticals (IE) Major Business
Table 77. Mallinckrodt Pharmaceuticals (IE) Postoperative Pain Control Drug Product and Services
Table 78. Mallinckrodt Pharmaceuticals (IE) Postoperative Pain Control Drug Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Mallinckrodt Pharmaceuticals (IE) Recent Developments/Updates
Table 80. Mallinckrodt Pharmaceuticals (IE) Competitive Strengths & Weaknesses
Table 81. Pfizer (US) Basic Information, Manufacturing Base and Competitors
Table 82. Pfizer (US) Major Business
Table 83. Pfizer (US) Postoperative Pain Control Drug Product and Services
Table 84. Pfizer (US) Postoperative Pain Control Drug Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Pfizer (US) Recent Developments/Updates
Table 86. Pfizer (US) Competitive Strengths & Weaknesses
Table 87. Novartis (CH) Basic Information, Manufacturing Base and Competitors
Table 88. Novartis (CH) Major Business
Table 89. Novartis (CH) Postoperative Pain Control Drug Product and Services
Table 90. Novartis (CH) Postoperative Pain Control Drug Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. Novartis (CH) Recent Developments/Updates
Table 92. Novartis (CH) Competitive Strengths & Weaknesses
Table 93. Eli Lilly (US) Basic Information, Manufacturing Base and Competitors
Table 94. Eli Lilly (US) Major Business
Table 95. Eli Lilly (US) Postoperative Pain Control Drug Product and Services
Table 96. Eli Lilly (US) Postoperative Pain Control Drug Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. Eli Lilly (US) Recent Developments/Updates
Table 98. Eli Lilly (US) Competitive Strengths & Weaknesses
Table 99. Teva Pharmaceutical Industries (IL) Basic Information, Manufacturing Base and Competitors
Table 100. Teva Pharmaceutical Industries (IL) Major Business
Table 101. Teva Pharmaceutical Industries (IL) Postoperative Pain Control Drug Product and Services
Table 102. Teva Pharmaceutical Industries (IL) Postoperative Pain Control Drug Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. Teva Pharmaceutical Industries (IL) Recent Developments/Updates
Table 104. Teva Pharmaceutical Industries (IL) Competitive Strengths & Weaknesses
Table 105. Bayer (DE) Basic Information, Manufacturing Base and Competitors
Table 106. Bayer (DE) Major Business
Table 107. Bayer (DE) Postoperative Pain Control Drug Product and Services
Table 108. Bayer (DE) Postoperative Pain Control Drug Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. Bayer (DE) Recent Developments/Updates
Table 110. Bayer (DE) Competitive Strengths & Weaknesses
Table 111. Pacira BioSciences (US) Basic Information, Manufacturing Base and Competitors
Table 112. Pacira BioSciences (US) Major Business
Table 113. Pacira BioSciences (US) Postoperative Pain Control Drug Product and Services
Table 114. Pacira BioSciences (US) Postoperative Pain Control Drug Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. Pacira BioSciences (US) Recent Developments/Updates
Table 116. Pacira BioSciences (US) Competitive Strengths & Weaknesses
Table 117. Trevena (US) Basic Information, Manufacturing Base and Competitors
Table 118. Trevena (US) Major Business
Table 119. Trevena (US) Postoperative Pain Control Drug Product and Services
Table 120. Trevena (US) Postoperative Pain Control Drug Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. Trevena (US) Recent Developments/Updates
Table 122. Trevena (US) Competitive Strengths & Weaknesses
Table 123. Vertex Pharmaceuticals (US) Basic Information, Manufacturing Base and Competitors
Table 124. Vertex Pharmaceuticals (US) Major Business
Table 125. Vertex Pharmaceuticals (US) Postoperative Pain Control Drug Product and Services
Table 126. Vertex Pharmaceuticals (US) Postoperative Pain Control Drug Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 127. Vertex Pharmaceuticals (US) Recent Developments/Updates
Table 128. Vertex Pharmaceuticals (US) Competitive Strengths & Weaknesses
Table 129. Heron Therapeutics (US) Basic Information, Manufacturing Base and Competitors
Table 130. Heron Therapeutics (US) Major Business
Table 131. Heron Therapeutics (US) Postoperative Pain Control Drug Product and Services
Table 132. Heron Therapeutics (US) Postoperative Pain Control Drug Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 133. Heron Therapeutics (US) Recent Developments/Updates
Table 134. Heron Therapeutics (US) Competitive Strengths & Weaknesses
Table 135. Nanjing Delova Biotech (CN) Basic Information, Manufacturing Base and Competitors
Table 136. Nanjing Delova Biotech (CN) Major Business
Table 137. Nanjing Delova Biotech (CN) Postoperative Pain Control Drug Product and Services
Table 138. Nanjing Delova Biotech (CN) Postoperative Pain Control Drug Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 139. Nanjing Delova Biotech (CN) Recent Developments/Updates
Table 140. Nanjing Delova Biotech (CN) Competitive Strengths & Weaknesses
Table 141. Jiangsu Nhwa Pharmaceutical (CN) Basic Information, Manufacturing Base and Competitors
Table 142. Jiangsu Nhwa Pharmaceutical (CN) Major Business
Table 143. Jiangsu Nhwa Pharmaceutical (CN) Postoperative Pain Control Drug Product and Services
Table 144. Jiangsu Nhwa Pharmaceutical (CN) Postoperative Pain Control Drug Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 145. Jiangsu Nhwa Pharmaceutical (CN) Recent Developments/Updates
Table 146. Jiangsu Nhwa Pharmaceutical (CN) Competitive Strengths & Weaknesses
Table 147. Global Key Players of Postoperative Pain Control Drug Upstream (Raw Materials)
Table 148. Global Postoperative Pain Control Drug Typical Customers
Table 149. Postoperative Pain Control Drug Typical Distributors
Table 1. World Postoperative Pain Control Drug Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Postoperative Pain Control Drug Production Value by Region (2021-2026) & (USD Million)
Table 3. World Postoperative Pain Control Drug Production Value by Region (2027-2032) & (USD Million)
Table 4. World Postoperative Pain Control Drug Production Value Market Share by Region (2021-2026)
Table 5. World Postoperative Pain Control Drug Production Value Market Share by Region (2027-2032)
Table 6. World Postoperative Pain Control Drug Production by Region (2021-2026) & (K Dose)
Table 7. World Postoperative Pain Control Drug Production by Region (2027-2032) & (K Dose)
Table 8. World Postoperative Pain Control Drug Production Market Share by Region (2021-2026)
Table 9. World Postoperative Pain Control Drug Production Market Share by Region (2027-2032)
Table 10. World Postoperative Pain Control Drug Average Price by Region (2021-2026) & (US$/Dose)
Table 11. World Postoperative Pain Control Drug Average Price by Region (2027-2032) & (US$/Dose)
Table 12. Postoperative Pain Control Drug Major Market Trends
Table 13. World Postoperative Pain Control Drug Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Dose)
Table 14. World Postoperative Pain Control Drug Consumption by Region (2021-2026) & (K Dose)
Table 15. World Postoperative Pain Control Drug Consumption Forecast by Region (2027-2032) & (K Dose)
Table 16. World Postoperative Pain Control Drug Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Postoperative Pain Control Drug Producers in 2025
Table 18. World Postoperative Pain Control Drug Production by Manufacturer (2021-2026) & (K Dose)
Table 19. Production Market Share of Key Postoperative Pain Control Drug Producers in 2025
Table 20. World Postoperative Pain Control Drug Average Price by Manufacturer (2021-2026) & (US$/Dose)
Table 21. Global Postoperative Pain Control Drug Company Evaluation Quadrant
Table 22. World Postoperative Pain Control Drug Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Postoperative Pain Control Drug Production Site of Key Manufacturer
Table 24. Postoperative Pain Control Drug Market: Company Product Type Footprint
Table 25. Postoperative Pain Control Drug Market: Company Product Application Footprint
Table 26. Postoperative Pain Control Drug Competitive Factors
Table 27. Postoperative Pain Control Drug New Entrant and Capacity Expansion Plans
Table 28. Postoperative Pain Control Drug Mergers & Acquisitions Activity
Table 29. United States VS China Postoperative Pain Control Drug Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Postoperative Pain Control Drug Production Comparison, (2021 & 2025 & 2032) & (K Dose)
Table 31. United States VS China Postoperative Pain Control Drug Consumption Comparison, (2021 & 2025 & 2032) & (K Dose)
Table 32. United States Based Postoperative Pain Control Drug Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Postoperative Pain Control Drug Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Postoperative Pain Control Drug Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Postoperative Pain Control Drug Production (2021-2026) & (K Dose)
Table 36. United States Based Manufacturers Postoperative Pain Control Drug Production Market Share (2021-2026)
Table 37. China Based Postoperative Pain Control Drug Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Postoperative Pain Control Drug Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Postoperative Pain Control Drug Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Postoperative Pain Control Drug Production, (2021-2026) & (K Dose)
Table 41. China Based Manufacturers Postoperative Pain Control Drug Production Market Share (2021-2026)
Table 42. Rest of World Based Postoperative Pain Control Drug Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Postoperative Pain Control Drug Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Postoperative Pain Control Drug Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Postoperative Pain Control Drug Production, (2021-2026) & (K Dose)
Table 46. Rest of World Based Manufacturers Postoperative Pain Control Drug Production Market Share (2021-2026)
Table 47. World Postoperative Pain Control Drug Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Postoperative Pain Control Drug Production by Type (2021-2026) & (K Dose)
Table 49. World Postoperative Pain Control Drug Production by Type (2027-2032) & (K Dose)
Table 50. World Postoperative Pain Control Drug Production Value by Type (2021-2026) & (USD Million)
Table 51. World Postoperative Pain Control Drug Production Value by Type (2027-2032) & (USD Million)
Table 52. World Postoperative Pain Control Drug Average Price by Type (2021-2026) & (US$/Dose)
Table 53. World Postoperative Pain Control Drug Average Price by Type (2027-2032) & (US$/Dose)
Table 54. World Postoperative Pain Control Drug Production Value by Dosage, (USD Million), 2021 & 2025 & 2032
Table 55. World Postoperative Pain Control Drug Production by Dosage (2021-2026) & (K Dose)
Table 56. World Postoperative Pain Control Drug Production by Dosage (2027-2032) & (K Dose)
Table 57. World Postoperative Pain Control Drug Production Value by Dosage (2021-2026) & (USD Million)
Table 58. World Postoperative Pain Control Drug Production Value by Dosage (2027-2032) & (USD Million)
Table 59. World Postoperative Pain Control Drug Average Price by Dosage (2021-2026) & (US$/Dose)
Table 60. World Postoperative Pain Control Drug Average Price by Dosage (2027-2032) & (US$/Dose)
Table 61. World Postoperative Pain Control Drug Production Value by Action Area, (USD Million), 2021 & 2025 & 2032
Table 62. World Postoperative Pain Control Drug Production by Action Area (2021-2026) & (K Dose)
Table 63. World Postoperative Pain Control Drug Production by Action Area (2027-2032) & (K Dose)
Table 64. World Postoperative Pain Control Drug Production Value by Action Area (2021-2026) & (USD Million)
Table 65. World Postoperative Pain Control Drug Production Value by Action Area (2027-2032) & (USD Million)
Table 66. World Postoperative Pain Control Drug Average Price by Action Area (2021-2026) & (US$/Dose)
Table 67. World Postoperative Pain Control Drug Average Price by Action Area (2027-2032) & (US$/Dose)
Table 68. World Postoperative Pain Control Drug Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Postoperative Pain Control Drug Production by Application (2021-2026) & (K Dose)
Table 70. World Postoperative Pain Control Drug Production by Application (2027-2032) & (K Dose)
Table 71. World Postoperative Pain Control Drug Production Value by Application (2021-2026) & (USD Million)
Table 72. World Postoperative Pain Control Drug Production Value by Application (2027-2032) & (USD Million)
Table 73. World Postoperative Pain Control Drug Average Price by Application (2021-2026) & (US$/Dose)
Table 74. World Postoperative Pain Control Drug Average Price by Application (2027-2032) & (US$/Dose)
Table 75. Mallinckrodt Pharmaceuticals (IE) Basic Information, Manufacturing Base and Competitors
Table 76. Mallinckrodt Pharmaceuticals (IE) Major Business
Table 77. Mallinckrodt Pharmaceuticals (IE) Postoperative Pain Control Drug Product and Services
Table 78. Mallinckrodt Pharmaceuticals (IE) Postoperative Pain Control Drug Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Mallinckrodt Pharmaceuticals (IE) Recent Developments/Updates
Table 80. Mallinckrodt Pharmaceuticals (IE) Competitive Strengths & Weaknesses
Table 81. Pfizer (US) Basic Information, Manufacturing Base and Competitors
Table 82. Pfizer (US) Major Business
Table 83. Pfizer (US) Postoperative Pain Control Drug Product and Services
Table 84. Pfizer (US) Postoperative Pain Control Drug Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Pfizer (US) Recent Developments/Updates
Table 86. Pfizer (US) Competitive Strengths & Weaknesses
Table 87. Novartis (CH) Basic Information, Manufacturing Base and Competitors
Table 88. Novartis (CH) Major Business
Table 89. Novartis (CH) Postoperative Pain Control Drug Product and Services
Table 90. Novartis (CH) Postoperative Pain Control Drug Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. Novartis (CH) Recent Developments/Updates
Table 92. Novartis (CH) Competitive Strengths & Weaknesses
Table 93. Eli Lilly (US) Basic Information, Manufacturing Base and Competitors
Table 94. Eli Lilly (US) Major Business
Table 95. Eli Lilly (US) Postoperative Pain Control Drug Product and Services
Table 96. Eli Lilly (US) Postoperative Pain Control Drug Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. Eli Lilly (US) Recent Developments/Updates
Table 98. Eli Lilly (US) Competitive Strengths & Weaknesses
Table 99. Teva Pharmaceutical Industries (IL) Basic Information, Manufacturing Base and Competitors
Table 100. Teva Pharmaceutical Industries (IL) Major Business
Table 101. Teva Pharmaceutical Industries (IL) Postoperative Pain Control Drug Product and Services
Table 102. Teva Pharmaceutical Industries (IL) Postoperative Pain Control Drug Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. Teva Pharmaceutical Industries (IL) Recent Developments/Updates
Table 104. Teva Pharmaceutical Industries (IL) Competitive Strengths & Weaknesses
Table 105. Bayer (DE) Basic Information, Manufacturing Base and Competitors
Table 106. Bayer (DE) Major Business
Table 107. Bayer (DE) Postoperative Pain Control Drug Product and Services
Table 108. Bayer (DE) Postoperative Pain Control Drug Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. Bayer (DE) Recent Developments/Updates
Table 110. Bayer (DE) Competitive Strengths & Weaknesses
Table 111. Pacira BioSciences (US) Basic Information, Manufacturing Base and Competitors
Table 112. Pacira BioSciences (US) Major Business
Table 113. Pacira BioSciences (US) Postoperative Pain Control Drug Product and Services
Table 114. Pacira BioSciences (US) Postoperative Pain Control Drug Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. Pacira BioSciences (US) Recent Developments/Updates
Table 116. Pacira BioSciences (US) Competitive Strengths & Weaknesses
Table 117. Trevena (US) Basic Information, Manufacturing Base and Competitors
Table 118. Trevena (US) Major Business
Table 119. Trevena (US) Postoperative Pain Control Drug Product and Services
Table 120. Trevena (US) Postoperative Pain Control Drug Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. Trevena (US) Recent Developments/Updates
Table 122. Trevena (US) Competitive Strengths & Weaknesses
Table 123. Vertex Pharmaceuticals (US) Basic Information, Manufacturing Base and Competitors
Table 124. Vertex Pharmaceuticals (US) Major Business
Table 125. Vertex Pharmaceuticals (US) Postoperative Pain Control Drug Product and Services
Table 126. Vertex Pharmaceuticals (US) Postoperative Pain Control Drug Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 127. Vertex Pharmaceuticals (US) Recent Developments/Updates
Table 128. Vertex Pharmaceuticals (US) Competitive Strengths & Weaknesses
Table 129. Heron Therapeutics (US) Basic Information, Manufacturing Base and Competitors
Table 130. Heron Therapeutics (US) Major Business
Table 131. Heron Therapeutics (US) Postoperative Pain Control Drug Product and Services
Table 132. Heron Therapeutics (US) Postoperative Pain Control Drug Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 133. Heron Therapeutics (US) Recent Developments/Updates
Table 134. Heron Therapeutics (US) Competitive Strengths & Weaknesses
Table 135. Nanjing Delova Biotech (CN) Basic Information, Manufacturing Base and Competitors
Table 136. Nanjing Delova Biotech (CN) Major Business
Table 137. Nanjing Delova Biotech (CN) Postoperative Pain Control Drug Product and Services
Table 138. Nanjing Delova Biotech (CN) Postoperative Pain Control Drug Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 139. Nanjing Delova Biotech (CN) Recent Developments/Updates
Table 140. Nanjing Delova Biotech (CN) Competitive Strengths & Weaknesses
Table 141. Jiangsu Nhwa Pharmaceutical (CN) Basic Information, Manufacturing Base and Competitors
Table 142. Jiangsu Nhwa Pharmaceutical (CN) Major Business
Table 143. Jiangsu Nhwa Pharmaceutical (CN) Postoperative Pain Control Drug Product and Services
Table 144. Jiangsu Nhwa Pharmaceutical (CN) Postoperative Pain Control Drug Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 145. Jiangsu Nhwa Pharmaceutical (CN) Recent Developments/Updates
Table 146. Jiangsu Nhwa Pharmaceutical (CN) Competitive Strengths & Weaknesses
Table 147. Global Key Players of Postoperative Pain Control Drug Upstream (Raw Materials)
Table 148. Global Postoperative Pain Control Drug Typical Customers
Table 149. Postoperative Pain Control Drug Typical Distributors
LIST OF FIGURES
Figure 1. Postoperative Pain Control Drug Picture
Figure 2. World Postoperative Pain Control Drug Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Postoperative Pain Control Drug Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Postoperative Pain Control Drug Production (2021-2032) & (K Dose)
Figure 5. World Postoperative Pain Control Drug Average Price (2021-2032) & (US$/Dose)
Figure 6. World Postoperative Pain Control Drug Production Value Market Share by Region (2021-2032)
Figure 7. World Postoperative Pain Control Drug Production Market Share by Region (2021-2032)
Figure 8. North America Postoperative Pain Control Drug Production (2021-2032) & (K Dose)
Figure 9. Europe Postoperative Pain Control Drug Production (2021-2032) & (K Dose)
Figure 10. China Postoperative Pain Control Drug Production (2021-2032) & (K Dose)
Figure 11. Japan Postoperative Pain Control Drug Production (2021-2032) & (K Dose)
Figure 12. Postoperative Pain Control Drug Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Postoperative Pain Control Drug Consumption (2021-2032) & (K Dose)
Figure 15. World Postoperative Pain Control Drug Consumption Market Share by Region (2021-2032)
Figure 16. United States Postoperative Pain Control Drug Consumption (2021-2032) & (K Dose)
Figure 17. China Postoperative Pain Control Drug Consumption (2021-2032) & (K Dose)
Figure 18. Europe Postoperative Pain Control Drug Consumption (2021-2032) & (K Dose)
Figure 19. Japan Postoperative Pain Control Drug Consumption (2021-2032) & (K Dose)
Figure 20. South Korea Postoperative Pain Control Drug Consumption (2021-2032) & (K Dose)
Figure 21. ASEAN Postoperative Pain Control Drug Consumption (2021-2032) & (K Dose)
Figure 22. India Postoperative Pain Control Drug Consumption (2021-2032) & (K Dose)
Figure 23. Producer Shipments of Postoperative Pain Control Drug by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 24. Global Four-firm Concentration Ratios (CR4) for Postoperative Pain Control Drug Markets in 2025
Figure 25. Global Four-firm Concentration Ratios (CR8) for Postoperative Pain Control Drug Markets in 2025
Figure 26. United States VS China: Postoperative Pain Control Drug Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: Postoperative Pain Control Drug Production Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Postoperative Pain Control Drug Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States Based Manufacturers Postoperative Pain Control Drug Production Market Share 2025
Figure 30. China Based Manufacturers Postoperative Pain Control Drug Production Market Share 2025
Figure 31. Rest of World Based Manufacturers Postoperative Pain Control Drug Production Market Share 2025
Figure 32. World Postoperative Pain Control Drug Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 33. World Postoperative Pain Control Drug Production Value Market Share by Type in 2025
Figure 34. Opioids
Figure 35. NSAIDs
Figure 36. Local Anesthetics
Figure 37. Tricyclic Antidepressants
Figure 38. Antiepileptic Drugs
Figure 39. Others
Figure 40. World Postoperative Pain Control Drug Production Market Share by Type (2021-2032)
Figure 41. World Postoperative Pain Control Drug Production Value Market Share by Type (2021-2032)
Figure 42. World Postoperative Pain Control Drug Average Price by Type (2021-2032) & (US$/Dose)
Figure 43. World Postoperative Pain Control Drug Production Value by Dosage, (USD Million), 2021 & 2025 & 2032
Figure 44. World Postoperative Pain Control Drug Production Value Market Share by Dosage in 2025
Figure 45. Intravenous
Figure 46. Oral
Figure 47. Others
Figure 48. World Postoperative Pain Control Drug Production Market Share by Dosage (2021-2032)
Figure 49. World Postoperative Pain Control Drug Production Value Market Share by Dosage (2021-2032)
Figure 50. World Postoperative Pain Control Drug Average Price by Dosage (2021-2032) & (US$/Dose)
Figure 51. World Postoperative Pain Control Drug Production Value by Action Area, (USD Million), 2021 & 2025 & 2032
Figure 52. World Postoperative Pain Control Drug Production Value Market Share by Action Area in 2025
Figure 53. Systemic
Figure 54. Regional
Figure 55. World Postoperative Pain Control Drug Production Market Share by Action Area (2021-2032)
Figure 56. World Postoperative Pain Control Drug Production Value Market Share by Action Area (2021-2032)
Figure 57. World Postoperative Pain Control Drug Average Price by Action Area (2021-2032) & (US$/Dose)
Figure 58. World Postoperative Pain Control Drug Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 59. World Postoperative Pain Control Drug Production Value Market Share by Application in 2025
Figure 60. Hospital Pharmacies
Figure 61. Retail Pharmacies
Figure 62. Online Pharmacies
Figure 63. Others
Figure 64. World Postoperative Pain Control Drug Production Market Share by Application (2021-2032)
Figure 65. World Postoperative Pain Control Drug Production Value Market Share by Application (2021-2032)
Figure 66. World Postoperative Pain Control Drug Average Price by Application (2021-2032) & (US$/Dose)
Figure 67. Postoperative Pain Control Drug Industry Chain
Figure 68. Postoperative Pain Control Drug Procurement Model
Figure 69. Postoperative Pain Control Drug Sales Model
Figure 70. Postoperative Pain Control Drug Sales Channels, Direct Sales, and Distribution
Figure 71. Methodology
Figure 72. Research Process and Data Source
Figure 1. Postoperative Pain Control Drug Picture
Figure 2. World Postoperative Pain Control Drug Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Postoperative Pain Control Drug Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Postoperative Pain Control Drug Production (2021-2032) & (K Dose)
Figure 5. World Postoperative Pain Control Drug Average Price (2021-2032) & (US$/Dose)
Figure 6. World Postoperative Pain Control Drug Production Value Market Share by Region (2021-2032)
Figure 7. World Postoperative Pain Control Drug Production Market Share by Region (2021-2032)
Figure 8. North America Postoperative Pain Control Drug Production (2021-2032) & (K Dose)
Figure 9. Europe Postoperative Pain Control Drug Production (2021-2032) & (K Dose)
Figure 10. China Postoperative Pain Control Drug Production (2021-2032) & (K Dose)
Figure 11. Japan Postoperative Pain Control Drug Production (2021-2032) & (K Dose)
Figure 12. Postoperative Pain Control Drug Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Postoperative Pain Control Drug Consumption (2021-2032) & (K Dose)
Figure 15. World Postoperative Pain Control Drug Consumption Market Share by Region (2021-2032)
Figure 16. United States Postoperative Pain Control Drug Consumption (2021-2032) & (K Dose)
Figure 17. China Postoperative Pain Control Drug Consumption (2021-2032) & (K Dose)
Figure 18. Europe Postoperative Pain Control Drug Consumption (2021-2032) & (K Dose)
Figure 19. Japan Postoperative Pain Control Drug Consumption (2021-2032) & (K Dose)
Figure 20. South Korea Postoperative Pain Control Drug Consumption (2021-2032) & (K Dose)
Figure 21. ASEAN Postoperative Pain Control Drug Consumption (2021-2032) & (K Dose)
Figure 22. India Postoperative Pain Control Drug Consumption (2021-2032) & (K Dose)
Figure 23. Producer Shipments of Postoperative Pain Control Drug by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 24. Global Four-firm Concentration Ratios (CR4) for Postoperative Pain Control Drug Markets in 2025
Figure 25. Global Four-firm Concentration Ratios (CR8) for Postoperative Pain Control Drug Markets in 2025
Figure 26. United States VS China: Postoperative Pain Control Drug Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: Postoperative Pain Control Drug Production Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Postoperative Pain Control Drug Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States Based Manufacturers Postoperative Pain Control Drug Production Market Share 2025
Figure 30. China Based Manufacturers Postoperative Pain Control Drug Production Market Share 2025
Figure 31. Rest of World Based Manufacturers Postoperative Pain Control Drug Production Market Share 2025
Figure 32. World Postoperative Pain Control Drug Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 33. World Postoperative Pain Control Drug Production Value Market Share by Type in 2025
Figure 34. Opioids
Figure 35. NSAIDs
Figure 36. Local Anesthetics
Figure 37. Tricyclic Antidepressants
Figure 38. Antiepileptic Drugs
Figure 39. Others
Figure 40. World Postoperative Pain Control Drug Production Market Share by Type (2021-2032)
Figure 41. World Postoperative Pain Control Drug Production Value Market Share by Type (2021-2032)
Figure 42. World Postoperative Pain Control Drug Average Price by Type (2021-2032) & (US$/Dose)
Figure 43. World Postoperative Pain Control Drug Production Value by Dosage, (USD Million), 2021 & 2025 & 2032
Figure 44. World Postoperative Pain Control Drug Production Value Market Share by Dosage in 2025
Figure 45. Intravenous
Figure 46. Oral
Figure 47. Others
Figure 48. World Postoperative Pain Control Drug Production Market Share by Dosage (2021-2032)
Figure 49. World Postoperative Pain Control Drug Production Value Market Share by Dosage (2021-2032)
Figure 50. World Postoperative Pain Control Drug Average Price by Dosage (2021-2032) & (US$/Dose)
Figure 51. World Postoperative Pain Control Drug Production Value by Action Area, (USD Million), 2021 & 2025 & 2032
Figure 52. World Postoperative Pain Control Drug Production Value Market Share by Action Area in 2025
Figure 53. Systemic
Figure 54. Regional
Figure 55. World Postoperative Pain Control Drug Production Market Share by Action Area (2021-2032)
Figure 56. World Postoperative Pain Control Drug Production Value Market Share by Action Area (2021-2032)
Figure 57. World Postoperative Pain Control Drug Average Price by Action Area (2021-2032) & (US$/Dose)
Figure 58. World Postoperative Pain Control Drug Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 59. World Postoperative Pain Control Drug Production Value Market Share by Application in 2025
Figure 60. Hospital Pharmacies
Figure 61. Retail Pharmacies
Figure 62. Online Pharmacies
Figure 63. Others
Figure 64. World Postoperative Pain Control Drug Production Market Share by Application (2021-2032)
Figure 65. World Postoperative Pain Control Drug Production Value Market Share by Application (2021-2032)
Figure 66. World Postoperative Pain Control Drug Average Price by Application (2021-2032) & (US$/Dose)
Figure 67. Postoperative Pain Control Drug Industry Chain
Figure 68. Postoperative Pain Control Drug Procurement Model
Figure 69. Postoperative Pain Control Drug Sales Model
Figure 70. Postoperative Pain Control Drug Sales Channels, Direct Sales, and Distribution
Figure 71. Methodology
Figure 72. Research Process and Data Source
